脑部放疗,上午比下午敏感许多!
/ G: ^4 E; W, h& @! b, d# u1 u
) A( u$ z, V2 f7 v/ g# U5 i3 k) n& R( \2 \0 b/ L4 D
Cancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.' R8 |* T" c+ s) a
Gamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?
, _3 r2 I' ?6 c# h- E; J5 d$ URahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T., n2 _4 \* V P
SourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.) b' Z9 j; o% s. F) G: L
/ m! r! F; u6 u8 gAbstract
. S5 `. Q6 N- H" s' u" W: xBACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.& K( M5 `; V+ z( W+ B
" c& A; D+ E( K/ [; {METHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.9 \3 [2 c& R6 G9 x$ ?3 o( _8 L
# q# m5 G+ S: f- t4 N
RESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).( W' @0 R( X4 Z( j9 o6 R3 W' r1 E
7 m) x' H0 _1 i* W% f- w3 }4 o2 X7 T
CONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.
& Z. T: Q! z* P! }6 ?1 H9 L* `9 F6 b3 N
|